Inclusion criteria for the analysis were birth prior to 1993,
onset of type 1 diabetes before the age of 11 years, diabetes
manifestation between 1990 and 2000, documentation of
median HbA1c in the prepubertal, pubertal, and young adult
stage, together with documented insulin therapy.